National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Dictionary of Cancer Terms
Send to Printer
visilizumab

 A monoclonal antibody that binds to CD3 (a substance found on T-cells) and that is being studied as a treatment for graft-versus-host disease (GVHD). It belongs to the family of drugs called monoclonal antibodies.

Previous Definitions:virus-neutralizing antibody, viscera, visceral, visceral peritoneum, viscotoxin
Next Definitions:visual analog scale, visual pathway glioma, vital, vitamin, vitamin A